BI PRIME: Researchers at Pfizer are shifting their attention toward combining immune system-acting drugs with targeted therapies that act on genetic mutations in cancer patients to see if more people respond.
The FDA says that it's working with the drug company Pfizer to remedy a shortage of important injectable medications, including emergency syringes of epinephrine.